Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion From Calcineurin Inhibitors to Sirolimus in Kidney Transplant Recipients
NCT00452361Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Apr 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplantation (2 arms), sponsored by Pfizer. Primary endpoint: Change in Glomerular Filtration Rate From Baseline at 104 weeks. Started Apr 2007; status: terminated.
02
Drugs
sirolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00452361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452361.